Hillan Kenneth J.

CIK 0001600359

Head of TherapeuticsDirector

Filings

Latest Jun 16, 2025

Issuers covered

Showing

10 of 10

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Hillan Kenneth J.. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Hillan Kenneth J. has filed

Ticker	Issuer	Filings	Last filed
ME	23andme Holding Co.	5	Jun 7, 2023
SGMO	Sangamo Therapeutics, Inc	4	Jun 16, 2025
ZYME	Zymeworks Inc.	1	Dec 8, 2023

10 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Jun 16, 2025	SGMOSangamo Therapeutics, Inc	AGrant	25,000	$0.00	$0
Jun 6, 2024	SGMOSangamo Therapeutics, Inc	AGrant	25,000	$0.00	$0
Dec 8, 2023	ZYMEZymeworks Inc.	Holdings only	-	-	-
Jun 7, 2023	ME23andme Holding Co.	FTax	15,347	$2.08	$31,922
Jun 5, 2023	SGMOSangamo Therapeutics, Inc	AGrant	13,900	$0.00	$0
May 23, 2023	ME23andme Holding Co.	FTax	4,628	$1.94	$8,978
Feb 22, 2023	ME23andme Holding Co.	FTax	5,457	$2.87	$15,662
Jun 2, 2022	ME23andme Holding Co.	FTax	4,627	$2.82	$13,048
Mar 1, 2022	SGMOSangamo Therapeutics, Inc	AGrant	12,500	$0.00	$0
Feb 11, 2022	ME23andme Holding Co.	AGrant	214,091	$0.00	$0

Showing 1-10 of 10

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.